Magnetic Resonance Imaging
Volume 28, Issue 7 , Pages 1022-1029 , September 2010

Similarity in the metabolic profile in macroscopically involved and un-involved colonic mucosa in patients with inflammatory bowel disease: an in vitro proton (1H) MR spectroscopy study

  • Uma Sharma

      Affiliations

    • Department of NMR and MRI Facility, All India Institute of Medical Sciences, New Delhi-110 029, India
    • ,
  • Rajiv R. Singh

      Affiliations

    • Department of NMR and MRI Facility, All India Institute of Medical Sciences, New Delhi-110 029, India
    • ,
  • Vineet Ahuja

      Affiliations

    • Department of Gastroenterology and Human Nutrition, All India Institute of Medical Sciences, New Delhi-110 029, India
    • ,
  • Govind K. Makharia

      Affiliations

    • Department of Gastroenterology and Human Nutrition, All India Institute of Medical Sciences, New Delhi-110 029, India
    • ,
  • Naranamangalam R. Jagannathan

      Affiliations

    • Department of NMR and MRI Facility, All India Institute of Medical Sciences, New Delhi-110 029, India
    • Corresponding Author InformationCorresponding author. Tel.: +91 11 2659 3253; fax: +91 11 2658 8663.

Received 11 January 2010 ,Accepted 14 March 2010.

References 

  1. Baumgart DC, Carding SR. Inflammatory bowel disease: cause and immunobiology. Lancet. 2007;369:1627–1640
  2. Travis SPL, Stange EF, Lemann M, et al. European evidence-based consensus on the management of ulcerative colitis: Current management. J Crohn's Colitis. 2008;2:24–62
  3. Mathy C, Schneider K, Chen YY, et al. Gross versus microscopic pancolitis and the occurrence of neoplasia in ulcerative colitis. Inflamm Bowel Dis. 2003;9:351–355
  4. Ekbom A, Helmick C, Zack M, et al. Ulcerative colitis and colorectal cancer. A population-based study. N Engl J Med. 1990;323:1228–1233
  5. Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut. 2001;48:526–535
  6. Langholz E, Munkholm P, Davidsen M, et al. Changes in extent of ulcerative colitis: a study on the course and prognostic factors. Scand J Gastroenterol. 1996;31:260–266
  7. Moum B, Ekbom A, Vatn MH, et al. Change in the extent of colonoscopic and histological involvement in ulcerative colitis over time. Am J Gastroenterol. 1999;94:1564–1569
  8. Sharma U, Atri S, Sharma MC, et al. Skeletal muscle metabolism in Duchenne muscular dystrophy (DMD): an in-vitro proton NMR spectroscopy study. Magn Reson Imaging. 2003;21:145–153
  9. Gribbestad IS, Petersen SB, Fjøsne HE, et al. 1H NMR spectroscopic characterization of perchloric acid extracts from breast carcinomas and non-involved breast tissue. NMR Biomed. 1994;7:181–194
  10. Sharma U, Mehta A, Seenu V, et al. Biochemical characterization of metastatic lymph nodes of breast cancer patients by in-vitro 1H magnetic resonance spectroscopy: a pilot study. Magn Reson Imaging. 2004;22:697–706
  11. Moreno A, Arús C. Quantitative and qualitative characterization of 1H NMR spectra of colon tumors, normal mucosa and their perchloric acid extracts: decreased levels of myo-inositol in tumours can be detected in intact biopsies. NMR Biomed. 1996;9:33–45
  12. Brindle JT, Antti H, Holmes E, et al. Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using 1H-NMR-based metabonomics. Nat Med. 2002;8:1439–1444
  13. Bezabeh T, Somorjai RL, Smith IC, et al. The use of 1H magnetic resonance spectroscopy in inflammatory bowel diseases: distinguishing ulcerative colitis from Crohn's disease. Am J Gastroenterol. 2001;96:442–448
  14. Marchesi JR, Holmes E, Khan F, et al. Rapid and noninvasive metabonomic characterization of inflammatory bowel disease. J Proteome Res. 2007;6:546–551
  15. Balasubramanian K, Kumar S, Singh RR, et al. Metabolism of the colonic mucosa in patients with inflammatory bowel diseases: an in-vitro proton magnetic resonance spectroscopy study. Magn Reson Imaging. 2009;27:79–86
  16. Best WR, Becktel JM, Singleton JW, et al. Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology. 1976;70:439–444
  17. Silverberg MS, Satsangi J, Ahmad T. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol. 2005;19A:5–36
  18. Truelove SC, Witts LJ. Cortisone in ulcerative colitis; final report on a therapeutic trial. Br Med J. 1955;2:1041–1048
  19. Sharma U, Chaudhury K, Jagannathan NR, et al. A proton NMR study of the effect of a new intravasal injectable male contraceptive RISUG on seminal plasma metabolites. Reproduction. 2001;122:431–436
  20. Scheppach W. Effects of short chain fatty acids on gut morphology and function. Gut. 1994;35(1 Suppl):S35–S38
  21. Ahmad MS, Krishnan S, Ramakrishna BS, et al. Butyrate and glucose metabolism by colonocytes in experimental colitis in mice. Gut. 2000;46:493–499
  22. Binder HJ, Mehta P. Short-chain fatty acids stimulate active sodium and chloride absorption in-vitro in the rat distal colon. Gastroenterology. 1989;96:989–996
  23. Finnie IA, Dwarakanath AD, Taylor BA, et al. Colonic mucin synthesis is increased by sodium butyrate. Gut. 1995;36:93–99
  24. Roediger WE, Kapaniris O, Millard S. Lipogenesis from n-butyrate in colonocytes. Action of reducing agent and 5-aminosalicylic acid with relevance to ulcerative colitis. Mol Cell Biochem. 1992;118:113–118
  25. Roediger WE. Utilization of nutrients by isolated epithelial cells of the rat colon. Gastroenterology. 1982;83:424–429
  26. Ardawi MS, Newsholme EA. Fuel utilization in colonocytes of the rat. Biochem J. 1985;231:713–719
  27. Firmansyah A, Penn D, Lebenthal E. Isolated colonocyte metabolism of glucose, glutamine, n-butyrate, and beta-hydroxybutyrate in malnutrition. Gastroenterology. 1989;97:622–629
  28. Faintuch J. Nutritional abnormalities in inflammatory bowel disease. Rev Hosp Clin Fac Med Sao Paulo. 2002;57:129–130
  29. Smith RJ. Glutamine metabolism and its physiologic importance. JPEN J Parenter Enteral Nutr. 1990;14(4 Suppl):40S–44S
  30. Windmueller HG. Glutamine utilization by the small intestine. Adv Enzymol Relat Areas Mol Biol. 1982;53:201–237
  31. Michel V, Yuan Z, Ramsubir S, et al. Choline transport for phospholipid synthesis. Exp Biol Med (Maywood). 2006;231:490–504
  32. Holub BJ. Metabolism and function of myo-inositol and inositol phospholipids. Annu Rev Nutr. 1986;6:563–597
  33. Gassull MA. Nutrition and inflammatory bowel disease: its relation to pathophysiology, outcome and therapy. Dig Dis. 2003;21:220–227

PII: S0730-725X(10)00102-5

doi: 10.1016/j.mri.2010.03.039

Magnetic Resonance Imaging
Volume 28, Issue 7 , Pages 1022-1029 , September 2010

Article Tools

* Image Usage & Resolution